The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 7879859 B1

PDF
Full Text
Expired
Date of Patent:
Feb. 01, 2011

Filed:

Nov. 17, 2006
Applicants:

Yun-ping Zhou, East Bruswick, NJ (US);

Jing LI, Skillman, NJ (US);

Weizhen Wu, Tenafly, NJ (US);

Jin Shang, Short Hils, NJ (US);

John R. Thompson, Scotch Plains, NJ (US);

Nancy A. Thornberry, Westfield, NJ (US);

Inventors:

Yun-Ping Zhou, East Bruswick, NJ (US);

Jing Li, Skillman, NJ (US);

Weizhen Wu, Tenafly, NJ (US);

Jin Shang, Short Hils, NJ (US);

John R. Thompson, Scotch Plains, NJ (US);

Nancy A. Thornberry, Westfield, NJ (US);

Assignee:

Merck Sharp & Dohme Corp., Rahway, NJ (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/50 (2006.01); A61K 31/496 (2006.01); A61K 31/44 (2006.01); A61K 31/415 (2006.01); A61K 31/40 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present application features the use of the somatostatin subtype 3 receptor (SST3) as a target for affecting insulin secretion and for diagnosing diabetes related disorders. Glucose stimulated insulin secretion was found to be stimulated by knocking down expression of SST3 and through the use of a SST3 selective antagonist.


Find Patent Forward Citations

Zhou, Yun-Ping. (2011). Diagnosis and treatment of type 2 diabetes and other disorders (U.S. Patent No. 7879859). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/7879859

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…